Core Insights - Dianna Clarkson emphasizes the critical need for expanded capital access for small and mid-size businesses to foster economic stability and equality in the financial sector [1][3]. Company Overview - Dream Exchange is seeking to register as a national securities exchange to facilitate trading of securities and provide an "on-ramp" for small to mid-sized companies, particularly those led by minority entrepreneurs [6]. Entrepreneurial Background - Clarkson has a diverse entrepreneurial background, including founding a home healthcare business and co-founding the Life Luxe Jazz festival, which has given her firsthand experience with the challenges of securing investment and staffing [2]. Financial Education and Wealth Creation - Clarkson advocates for financial education and early investing, particularly for communities of color, to create generational wealth and overcome historical barriers to wealth creation [3]. Support for Small Businesses - Clarkson supports the Dream Exchange's mission to provide better access to capital for deserving companies, which is essential for local community growth through job creation and fair wages [4][5]. Economic Impact - Access to capital is viewed as fundamental for building a strong economy, as it not only funds companies but also supports local communities and enables families to build lasting wealth [5].

Core Insights - Zacks Premium offers various tools for investors to enhance their stock market engagement and confidence, including daily updates, research reports, and stock screens [1] Zacks Style Scores - The Zacks Style Scores are indicators designed to help investors select stocks likely to outperform the market within 30 days, rated from A to F based on value, growth, and momentum characteristics [2] - Stocks with higher Style Scores have better chances of outperforming the market, with A being the highest score [2] Value Score - The Value Style Score identifies attractive and discounted stocks using ratios such as P/E, PEG, Price/Sales, and Price/Cash Flow, appealing to value investors [3] Growth Score - The Growth Style Score focuses on a company's financial strength and future outlook, analyzing projected and historical earnings, sales, and cash flow to find stocks with sustainable long-term growth [4] Momentum Score - The Momentum Style Score helps investors capitalize on price trends, utilizing factors like one-week price changes and monthly earnings estimate changes to identify optimal entry points [5] VGM Score - The VGM Score combines all three Style Scores, providing a comprehensive indicator that evaluates stocks based on value, growth, and momentum, assisting in narrowing down investment choices [6] Zacks Rank - The Zacks Rank is a proprietary stock-rating model that simplifies portfolio building by using earnings estimate revisions, with 1 (Strong Buy) stocks achieving an average annual return of +23.93% since 1988, significantly outperforming the S&P 500 [7][8] Stock Selection Strategy - To maximize returns, investors should focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B, while 3 (Hold) ranked stocks should also have A or B scores for potential upside [10] - The direction of earnings estimate revisions is crucial; stocks with lower ranks (4 or 5) may still have good Style Scores but are likely to face declining earnings forecasts [11] Company Spotlight: BrightSpring Health Services, Inc. - BrightSpring Health Services, Inc. is a national healthcare services platform focusing on home and community-based care for complex patients, serving all 50 states [12] - The company holds a 1 (Strong Buy) Zacks Rank and a VGM Score of A, with a Value Style Score of B, supported by a forward P/E ratio of 27.86 [13] - Recent upward revisions in earnings estimates by six analysts for fiscal 2026 have increased the Zacks Consensus Estimate by $0.21 to $1.61 per share, with an average earnings surprise of +40.4% [13] - With strong rankings and Style Scores, BrightSpring Health Services is recommended for investors [14]

Core Insights - BrightSpring Health Services, Inc. (BTSG) is positioned to capitalize on the trend of complex care moving from hospitals to home settings, which increases demand for medication access and coordinated clinical services [1] - The company anticipates sequential improvement in 2026, with profitability expected to grow faster than revenue due to efficiency initiatives [1] Company Overview - BrightSpring operates a national home- and community-based platform that integrates pharmacy capabilities with provider care for medically complex patients across various payors [2] - The company is headquartered in Louisville, KY, and serves all 50 states [2] Operational Segments - Operations are divided into two segments: Pharmacy Solutions, focusing on medication dispensing and therapy management, and Provider Services, delivering clinical care primarily in the home [3] - Pharmacy Solutions generated $11.4 billion, or 88.7% of total revenue in fiscal 2025, while Provider Services contributed $1.5 billion, or 11.3% [5] Revenue Growth - In fiscal 2025, revenue reached $12.9 billion, a 28.2% increase from $10.1 billion in 2024 [5] - Specialty and infusion within Pharmacy Solutions grew to $9.1 billion, reflecting a significant growth trajectory [6] Payor Mix - The 2025 payor mix included Medicare Part D at 31.7%, Medicare Advantage at 17.6%, commercial at 24.1%, and Medicaid at 8.5% [7] Growth Catalysts - Specialty and infusion are identified as primary growth drivers, with a 43% year-over-year growth in Q4 [8][10] - Management expects over 16–20 limited-distribution launches in the next 12–18 months, which will enhance script volume and clinical management work [9] Financial Projections - For 2026, BTSG projects revenue between $14.45 billion and $15.0 billion, with adjusted EBITDA expected to be between $760 million and $790 million [12] - Provider Services is anticipated to grow at mid-to-high 20% rates, supported by the acquisition of Amedisys/LHC assets [13] Margin Expansion - Margin expansion in 2026 is expected to be driven by a shift towards higher-value specialty and infusion work, efficiency programs, and pricing initiatives [11] - A midyear generic launch in Q2 2026 is also expected to contribute positively to margins [12] Challenges and Mitigation - Home and community pharmacy faces near-term headwinds affecting script growth, attributed to offboarded customers and bankruptcies [16] - Management's mitigation plan includes targeted market focus, new sales hires, and pricing initiatives to stabilize growth [17][18] Monitoring Key Developments - Key developments to watch in 2026 include the cadence of limited-distribution drug wins, the timing of the generic launch, and integration milestones related to the Amedisys/LHC assets [19][20] Competitive Landscape - The home-based care landscape remains competitive, with significant players like Option Care Health and CVS Health, making execution and access critical for BTSG [21]

Core Insights - The company anticipates a performance surge in 2025 due to a successful three-year strategic transformation that aligns clinical capacity with preferred payers [1] - The 'Preferred Payer' strategy is identified as the main driver for margin stabilization, focusing staffing on partners willing to engage in enhanced reimbursement and value-based agreements [1] Revenue Growth - Private Duty Services (PDS) experienced a revenue growth of 10.2% per hour, attributed to a shift towards higher-reimbursement preferred payer volumes [1] - Home Health segment outperformed expectations by focusing on an episodic-only model, which now constitutes 78% of the segment's mix, supporting double-digit organic growth [1] Medical Solutions - Medical Solutions results were temporarily enhanced by a reserve release of $2.5 million to $3 million due to improved cash collections, although this segment is also transitioning towards a preferred payer strategy [1] Industry Context - The industry is facing a capacity constraint rather than a demand issue, with government and Managed Care Organization (MCO) partners actively seeking home-based solutions to lower total care costs [1]

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was approximately $662 million, a 27.4% increase year-over-year. Full year 2025 revenue was approximately $2.433 billion, representing a 20.2% increase over the prior year [5][18] - Adjusted EBITDA for Q4 was $85 million, a 54% increase year-over-year, while full year 2025 Adjusted EBITDA was $320.8 million, a 74.8% increase [5][18] - Consolidated gross margin for Q4 was $213.3 million, or 32.2% [18] Business Line Data and Key Metrics Changes - Private Duty Services revenue for Q4 was approximately $541 million, a 28.1% increase, driven by 12.4 million hours of care, a volume increase of 17.9% [19] - Home Health and Hospice revenue for Q4 was approximately $69.3 million, a 27.3% increase, with 10,400 total admissions, 78% of which were episodic [21] - Medical Solutions revenue for Q4 was $52.5 million, up 21.3%, with approximately 92,000 unique patients served [22] Market Data and Key Metrics Changes - Preferred payer agreements accounted for approximately 57% of total private duty services MCO volumes in Q4 [10] - The company aims to increase the number of preferred payer agreements from 30 to 38 by the end of 2026 [10] Company Strategy and Development Direction - The company is focused on five primary strategic initiatives for 2026, including strengthening partnerships with government and preferred payers, improving clinical outcomes, implementing AI and automation, growing through acquisitions, and engaging employees [16] - The acquisition of Family First Homecare is expected to close in Q2 2026, enhancing the company's service offerings in Florida [15][27] Management's Comments on Operating Environment and Future Outlook - The management noted that the demand for home and community-based care remains strong, with ongoing efforts to address labor market challenges [6][7] - For 2026, the company anticipates revenue in the range of $2.54 billion to $2.56 billion and Adjusted EBITDA between $318 million and $322 million [17][26] Other Important Information - The company achieved 10 rate enhancements in 2025, aligning with its government affairs strategy [8] - Cash generated by operating activities was $125.9 million, with free cash flow of $131 million [25] Q&A Session Summary Question: Impact of Family First acquisition on leverage - The acquisition is valued at about 7.5 times post-synergy EBITDA, with minimal short-term impact on leverage expected [29][30] Question: Geographic coverage of preferred provider arrangements - The company has secured most major payers in current geographies and aims to fill in gaps in states like Ohio and West Virginia [32][34] Question: Revenue contribution from Family First - Expected revenue from Family First is around $120 million, with a focus on Florida [38][39] Question: 2026 EBITDA bridge - The EBITDA guidance for 2026 is based on a normalized growth rate, with expectations of organic growth around 5% [41][44] Question: California home-based nursing rates - No significant changes are expected in California's budget for PDN rates, with advocacy efforts ongoing [64][66] Question: Travel reimbursement for caregivers - 80% of revenues are from shift care where mileage is not reimbursed, minimizing the impact of fuel prices [72][73] Question: Timeline for value-based arrangements with preferred payers - There is typically a lag of 6 to 18 months from signing a preferred payer to when value-based agreements start contributing to revenue [87]

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was approximately $662 million, a 27.4% increase year-over-year. Full year 2025 revenue was approximately $2.433 billion, representing a 20.2% increase over the prior year [5][18] - Adjusted EBITDA for Q4 was $85 million, a 54% increase year-over-year, while full year 2025 Adjusted EBITDA was $320.8 million, a 74.8% increase [5][18] - Consolidated gross margin for Q4 was $213.3 million, or 32.2% [18] Business Line Data and Key Metrics Changes - Private Duty Services revenue for Q4 was approximately $541 million, a 28.1% increase, driven by 12.4 million hours of care, a volume increase of 17.9% [19] - Home Health and Hospice revenue for Q4 was approximately $69.3 million, a 27.3% increase, with 10,400 total admissions, 78% of which were episodic [21] - Medical Solutions revenue for Q4 was $52.5 million, up 21.3% year-over-year, with approximately 92,000 unique patients served [22] Market Data and Key Metrics Changes - Preferred payer agreements accounted for approximately 57% of total private duty services MCO volumes in Q4 [10] - The company achieved 10 rate enhancements in 2025, aligning with its government affairs strategy [8] - The episodic payer mix for home health was 78% in Q4, with total episodic volume growth of 25% year-over-year [11] Company Strategy and Development Direction - The company is focused on strengthening partnerships with government and preferred payers to create additional capacity and growth [16] - Strategic initiatives for 2026 include improving clinical outcomes, implementing AI and automation for operational efficiency, and pursuing acquisitions [16] - The company aims to add 8 additional preferred payer agreements in 2026, targeting a total of 38 agreements by year-end [10] Management's Comments on Operating Environment and Future Outlook - Management noted that the demand for home and community-based care remains strong, with no demand problem in the industry [6][7] - The company anticipates 2026 revenue in the range of $2.54-$2.56 billion and Adjusted EBITDA of $318-$322 million, considering ongoing challenges [17][26] - Management expressed confidence in the caregiver hiring and retention trends, which have improved due to alignment with preferred payers [7] Other Important Information - The company is in the process of acquiring Family First Homecare, expected to close in Q2 2026, which will enhance its service offerings in Florida [15][26] - The company had liquidity of approximately $529 million at the end of Q4, with cash on hand of approximately $193 million [24] Q&A Session Summary Question: Impact of Family First acquisition on leverage - Management indicated that the acquisition would have a minimal short-term impact on leverage, with expectations to slightly decrease leverage over 2026 due to generated free cash flow [29][30] Question: Geographic coverage of preferred provider arrangements - Management confirmed that the additional agreements in 2025 and anticipated agreements in 2026 are focused on densifying current geographies, with plans to fill in states like Ohio and Kentucky [32][34] Question: Revenue contribution from Family First - Management expects Family First to contribute approximately $120 million in revenue, with integration efforts anticipated to be smooth [38][39] Question: Trends in episodic mix and membership impacts - Management expressed confidence in maintaining an episodic mix above 75% and noted that they are not concerned about trends in managed Medicare [51] Question: California home-based nursing rates outlook - Management does not expect any material changes in California's budget for home-based nursing rates for 2026, indicating a challenging environment [64] Question: Travel reimbursement for caregivers - Management clarified that 80% of revenues are from shift care where mileage is not reimbursed, minimizing the impact of rising oil prices [72][73]

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was approximately $662 million, a 27.4% increase year-over-year. Full year 2025 revenue was approximately $2.433 billion, representing a 20.2% increase over the prior year [4][18] - Adjusted EBITDA for Q4 was $85 million, a 54% increase year-over-year, while full year 2025 Adjusted EBITDA was $320.8 million, a 74.8% increase [4][18] - Consolidated gross margin for Q4 was $213.3 million, or 32.2% [18] Business Line Data and Key Metrics Changes - Private Duty Services revenue for Q4 was approximately $541 million, a 28.1% increase, driven by 12.4 million hours of care, a volume increase of 17.9% [19] - Home Health and Hospice revenue for Q4 was approximately $69.3 million, a 27.3% increase, with 10,400 total admissions, 78% of which were episodic [21] - Medical Solutions revenue for Q4 was $52.5 million, up 21.3% year-over-year, with approximately 92,000 unique patients served [22] Market Data and Key Metrics Changes - Preferred payer agreements accounted for approximately 57% of total private duty services MCO volumes in Q4 [10] - The company aims to increase the number of preferred payer agreements from 30 to 38 by the end of 2026 [10] Company Strategy and Development Direction - The company is focused on five primary strategic initiatives for 2026: strengthening partnerships with government and preferred payers, improving clinical outcomes, implementing AI and automation, growing through acquisitions, and engaging employees [16] - The acquisition of Family First Homecare is expected to close in Q2 2026, enhancing the company's service offerings in Florida [15][17] Management's Comments on Operating Environment and Future Outlook - Management noted that the demand for home and community-based care remains strong, with ongoing efforts to address labor market challenges [5][6] - The company anticipates 2026 revenue in the range of $2.54-$2.56 billion and Adjusted EBITDA between $318-$322 million, considering ongoing challenges in the operating environment [17][26] Other Important Information - The company achieved 10 rate enhancements in 2025, aligning with its government affairs strategy [8] - Cash generated by operating activities was $125.9 million, with free cash flow of $131 million for 2025 [25] Q&A Session Summary Question: Impact of Family First acquisition on leverage and margin contribution - Management expressed excitement about the acquisition, indicating minimal short-term impact on leverage and a plan to deleverage in 2026 [30][31] Question: Geographic coverage of preferred provider arrangements - Management confirmed that the additional agreements in 2025 and 2026 are focused on densifying current geographies, with plans to fill in states like Ohio and West Virginia [34][35] Question: Revenue contribution and KPIs from Family First - Expected revenue from Family First is around $120 million, with a focus on integration and leveraging existing payer relationships in Florida [40][41] Question: Trends in episodic mix and membership impacts - Management reported strong growth in episodic admissions and expressed confidence in the home health and hospice business despite membership volatility [51][52] Question: Travel reimbursement for caregivers and impact of fuel prices - Management clarified that 80% of revenues are from shift care with minimal impact from fuel prices, as most caregivers do not incur travel costs [74][75] Question: Replicating preferred payer strategy in home health - Management highlighted the success of the episodic payer mix strategy and the importance of clinical outcomes in driving payer relationships [81][82]

Financial Performance - Aveanna Healthcare reported revenue of $662.48 million for the quarter ended December 2025, reflecting a year-over-year increase of 27.4% [1] - The earnings per share (EPS) for the quarter was $0.17, up from $0.05 in the same quarter last year, indicating significant growth [1] - The reported revenue exceeded the Zacks Consensus Estimate of $627.12 million by 5.64%, while the EPS surpassed the consensus estimate of $0.12 by 38.78% [1] Key Metrics - Aveanna's hours worked (PDS) were reported at 12,361.00 hours, exceeding the two-analyst average estimate of 12,126.72 hours [4] - The revenue rate for MS was $570.53, compared to the two-analyst average estimate of $504.03 [4] - Unique patients served (UPS) for MS was 92, above the two-analyst average estimate of 88 [4] - Revenue for PDS was $540.71 million, surpassing the three-analyst average estimate of $526.82 million, with a year-over-year change of 28.1% [4] - Revenue for MS was reported at $52.49 million, exceeding the average estimate of $44.63 million by 21.3% year over year [4] - Revenue for HHH was $69.29 million, higher than the estimated $61.92 million, representing a 27.3% increase compared to the previous year [4] Stock Performance - Aveanna's shares have returned -6.6% over the past month, compared to a -3.6% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]

Market Overview - U.S. stock markets have experienced a downturn over the past three weeks due to geopolitical conflicts in the Middle East, particularly between the U.S.-Israel joint force and Iran, leading to increased crude oil and natural gas prices [1] - The Strait of Hormuz, a major oil supply line controlled by Iran, remains severely disturbed, raising concerns about global inflation [1] Stock Performance - A limited number of stocks have shown price strength during this downturn, with a focus on those that have recently been on a bull run [2] - Five stocks identified with strong price gains are Cardinal Infrastructure Group Inc. (CDNL), Escalade Inc. (ESCA), Century Aluminum Co. (CENX), BrightSpring Health Services Inc. (BTSG), and Constellium SE (CSTM) [2][7] Stock Analysis - Cardinal Infrastructure Group (CDNL) has seen a stock price increase of 34% in four weeks, with earnings estimates rising by 29.9% [7][8] - Escalade Inc. (ESCA) has experienced a price increase of 28.9% over the same period, with an expected earnings growth of 6.1% [10] - Century Aluminum Co. (CENX) has surged 15.6% in stock price, with an expected earnings growth rate exceeding 100% [13] - BrightSpring Health Services Inc. (BTSG) has advanced 9.5% in stock price, with an expected earnings growth rate of 61% [14] - Constellium SE (CSTM) has gained 7.5% in stock price, with an expected earnings growth rate of 6.8% [16] Investment Screening Criteria - Stocks were screened based on several parameters, including a percentage change in price over the last four weeks greater than zero and a percentage change over 12 weeks greater than 10% [4] - Additional criteria included a Zacks Rank of 1 (Strong Buy), an average broker rating of 1, a current price greater than $5, and a current price/52-week high-low range greater than 85% [5][6]

Core Insights - Addus HomeCare is focusing on operational recovery and growth in its personal care and hospice segments, particularly after disruptions caused by Medicaid redeterminations [4][6][7] Personal Care Business - Illinois, Texas, and New Mexico account for approximately 70% of Addus' personal care business, all of which faced operational disruptions due to Medicaid redetermination [1][6] - The company is prioritizing profitability by focusing on increasing hours per client rather than merely growing census numbers, aiming to attract clients with higher hour needs [2][7] - Management expects sequential census growth and improved year-over-year comparisons in the second half of 2026 as disruptions ease [6][8] Hospice Segment - A significant internal focus for 2025 is on rebuilding the hospice segment, with investments in leadership and sales training aimed at returning to pre-pandemic performance [3][20] - The company has seen positive progress in its hospice business and is optimistic about future performance [3] Regulatory and Policy Environment - Recent rate increases in Texas and New Mexico, with a 4% increase effective July 1, are expected to support the company's growth strategy, while Illinois is not anticipated to increase rates this year [5][18] - Addus has invested in a strong compliance program to address regulatory scrutiny and ensure proper billing practices [11][12] Labor and Technology - The labor environment for personal care has been favorable, with a need to maintain hiring metrics just above 105 hires per day to meet growth targets [15][16] - The rollout of a caregiver app is expected to improve fill rates and operational efficiency, with Illinois fill rates improving from the low 80% range to the upper 80% range [17][19] Acquisition Strategy - Addus plans to focus on smaller acquisitions within existing markets, typically valued at $10 million to $15 million, while remaining open to larger strategic deals if they align with company goals [21]